Quote For Targacept, Inc. TRGT.O
sector: Healthcare ·
industry: Biotechnology ·
As of
27 Nov 2009
22.46USD
$22.46
27 Nov 2009
-2.39%
$23.01
$22.19
68,598
$22.84
$22.03
$24.50
$1.50
3.74
258,789
News
Press Releases
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Skaletsky, Mark |
Chairman of the Board |
-- |
| DeBethizy, J. Donald |
President, Chief Executive Officer, Director |
761,957 |
| Musso, Alan |
Chief Financial Officer, Vice President, Treasurer, Assistant Secretary |
468,093 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
$622.15 |
| Shares Outstanding (Mil.) |
27.70 |
| Float (Mil.) |
22.00 |
| |
| Dividend Information |
| Yield % |
-99,999.99 |
| Annual Dividend ($ USD) |
0.00 |
| Payout Ratio(TTM) % |
-- |
| |
| Financial Strength |
| Quick Ratio |
6.66 |
| Current Ratio |
5.80 |
| LT Debt/Equity |
4.98 |
| Total Debt/Equity |
8.02 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
-- |
| Price/Sales(TTM) |
22.10 |
| Price/Book(TTM) |
12.12 |
| Price/Cash Flow(TTM) |
-- |
| |
|
| Per Share Data |
| Earnings(TTM) |
$-0.74 |
| Sales(TTM) |
$1.11 |
| Book Value(MRQ) |
$1.85 |
| Cash Flow(TTM) |
$-0.65 |
| Cash(MRQ) |
$2.98 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
-33.78 |
| Return on Assets(TTM) |
-19.42 |
| Return on Investment(TTM) |
-22.75 |
| |
|
| Margins |
| Gross Margin(TTM) % |
96.89 |
| Operating Margin(TTM) % |
-69.46 |
| Profit Margin(TTM) % |
-65.46 |
|
| |
|
UK
US
- Europe
- Asia
- UK Most Actives